期刊文献+

确定维持治疗获益的非小细胞肺癌患者:来自JMEN试验的后续分析 被引量:1

Identifying the Target NSCLC Patient for Maintenance Therapy: An Analysis from JMEN
下载PDF
导出
摘要 1文献来源 Obasaju C, Bowman L, Wang P, et al. Identifying the target NSCLC patient for maintenance therapy: An analysis from a placebo-controlled,
出处 《循证医学》 CSCD 2014年第1期37-40,共4页 The Journal of Evidence-Based Medicine
关键词 非小细胞肺癌 维持治疗 肺癌症状评估 培美曲塞 生存 non-small cell lung cancer maintenance therapy lung cancer symptom assessment Pemetrexed survival
  • 引文网络
  • 相关文献

参考文献2

  • 1Ciuleanu T, Brodowicz T, Zielinski C, et al. Maintenance Pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase 3 study [J]. Lancet, 2009,374 (9699) : 1432-1440.
  • 2Perol M, Chouaid C, Mil!.eron BJ, et al. Maintenance with either Gemcitabine or Erlotinib versus observation with predefined second-line treatment after Cisplatin-Gemcitabine induction chemotherapy in advanced NSCLC: IFCT-GFPC 0502 phase Ⅲ study [J]. J Clin Oncol, 2010,28 (Suppl 15s):Abstr 7507.

同被引文献5

引证文献1

;
使用帮助 返回顶部